BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34521295)

  • 21. Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur.
    Raman S; Dada R; Nag TC; Yadav CS
    Indian J Med Res; 2021 Jun; 154(6):849-856. PubMed ID: 35662090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson's disease in Chinese patients.
    Xu Q; Lai Q; Wang J; Zhuang L; Cheng L; Mo Y; Liu L; Zhao Z; Zhang Y; Weng S; Qiao S
    Acta Neurol Belg; 2022 Dec; 122(6):1557-1566. PubMed ID: 34845645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.
    Liu Y; Sun MG; Jiang R; Ding R; Che Z; Chen YY; Yao CJ; Zhu XX; Cao JY
    J Assist Reprod Genet; 2014 Mar; 31(3):363-70. PubMed ID: 24435452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the PAI-1 4G/5G Gene Polymorphism and the Risk of Systemic Lupus Erythematosus/Lupus Nephritis.
    Li W; Mao S; Wu L; Shi W; Zhang J; Wang Z
    Crit Rev Eukaryot Gene Expr; 2019; 29(1):85-94. PubMed ID: 31002598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAI-1 4G/4G Genotype Is Associated with Recurrent Implantation Failure: a Systematic Review and Meta-analysis.
    Zeng H; He D; Hu L; Ma W; Quan S
    Reprod Sci; 2021 Nov; 28(11):3051-3060. PubMed ID: 34019258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels.
    Kathiresan S; Gabriel SB; Yang Q; Lochner AL; Larson MG; Levy D; Tofler GH; Hirschhorn JN; O'Donnell CJ
    Circulation; 2005 Sep; 112(12):1728-35. PubMed ID: 16172282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of PAI-1 4G/5G and ACE I/D Polymorphisms with Susceptibility to Pediatric Sepsis: Evidence from a Meta-Analysis.
    Jarahzadeh MH; Jafari M; Seifi-Shalamzari N; Ferdosian F; Bahrami R; Raee-Ezzabadi A; Nafei Z; Shajari A; Mirjalili SR; Neamatzadeh H
    Fetal Pediatr Pathol; 2022 Apr; 41(2):242-258. PubMed ID: 32536239
    [No Abstract]   [Full Text] [Related]  

  • 28. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
    Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T
    PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.
    Zhang T; Pang C; Li N; Zhou E; Zhao K
    BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
    Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
    Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between plasminogen activator inhibitor-1 4G/5G gene polymorphism and immunoglobulin A nephropathy susceptibility.
    Zhou TB; Jiang ZP
    J Recept Signal Transduct Res; 2015 Feb; 35(1):63-6. PubMed ID: 24918969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta-analysis.
    Huang G; Wang P; Li T; Deng X
    Clin Cardiol; 2019 Dec; 42(12):1232-1238. PubMed ID: 31701558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
    Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
    Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH
    Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.
    Bayramoglu A; Gunes HV; Metintas M; Degirmenci I; Guler HI; Ustuner C; Musmul A
    Genet Test Mol Biomarkers; 2014 Aug; 18(8):587-90. PubMed ID: 24955483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
    Lin S; Huiya Z; Bo L; Wei W; Yongmei G
    Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.
    Tabaei S; Omraninava M; Mehranfar S; Motallebnezhad M; Tabaee SS
    Biochem Genet; 2022 Oct; 60(5):1409-1445. PubMed ID: 35039979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of PAI-1 4G/5G and -844G/A gene polymorphisms and changes in PAI-1/tissue plasminogen activator levels in myocardial infarction: a case-control study.
    Abboud N; Ghazouani L; Saidi S; Ben-Hadj-Khalifa S; Addad F; Almawi WY; Mahjoub T
    Genet Test Mol Biomarkers; 2010 Feb; 14(1):23-7. PubMed ID: 19929406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.